Intellectual Property Law

The United States Patent and Trademark Office (USPTO)announced plans for the Patent Trial and Appeal Board (PTAB) to extend the Motion to Amend (MTA) pilot program. Read more

This week, the United States Department of Justice announced that Viktors Suhorukovs, a citizen of Latvia, was sentenced to more than four years in federal prison and ordered to pay over $4.5 million in restitution after pleading guilty to mail fraud in a multi-million-dollar scheme to defraud owners of U.S. trademark registrations. Read more

Two years ago, when I assumed my role as Chair of the IP Section, I – like everyone else – could not have imagined what the last two years would hold. Read more

The United States Patent and Trademark Office (USPTO) has extended the deadline for submitting comments on the state of patent eligibility jurisprudence, and its effect on investment and innovation in the United States, to October 15, 2021. Read more

The United States Patent and Trademark Office (USPTO) has published a notice in the Federal Register announcing a modification to its COVID-19 Prioritized Examination Pilot Program. Read more

The Patent Trial and Appeal Board (PTAB) has published an update to its Orange Book patent/biologic patent study. Read more

On August 4, 2021, the Department of Commerce filed for federal registration of the USPTO marks in an effort to protect trademark customers from misleading solicitations and trademark filing scams. Read more

On June 29, as a result of the recent Supreme Court decision in U.S. v. Arthrex, Inc., the United States Patent and Trademark Office (USPTO) implemented an interim procedure whereby review of a Patent Trial and Appeal Board (PTAB) final written decision in an inter partes, post-grant, or covered business method review may be initiated sua sponte by the Director or requested by a party to a PTAB proceeding. Read more

On June 29, as a result of the recent Supreme Court decision in U.S. v. Arthrex, Inc., the USPTO implemented an interim procedure whereby review of a Patent Trial and Appeal Board (PTAB) final written decision in an inter partes, post-grant, or covered business method review may be initiated sua sponte by the Director or requested by a party to a PTAB proceeding. Read more

The USPTO is seeking comments from the public regarding the impact of patent eligibility jurisprudence in the United States since the Supreme Court’s 2016 decisions in Mayo and Alice and subsequent Federal Circuit decisions applying the Supreme Court’s legal framework. Read more